Gaetano Guglielmino - 22 Jan 2026 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role: Chief Commercial Officer
Signature: /s/ Lisa Taylor as Attorney-in-fact for Gaetano Guglielmino
Issuer symbol: TMCI
Transactions as of: 22 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 23 Jan 2026, 21:30:09 UTC
Previous filing: 03 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Guglielmino Gaetano	Chief Commercial Officer	100 PALMETTO PARK PLACE, PONTE VEDRA	/s/ Lisa Taylor as Attorney-in-fact for Gaetano Guglielmino	23 Jan 2026	0002047624

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TMCI	Common Stock	Award	$0	+150,000	+44%	$0.000000	490,901	22 Jan 2026	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F2	Includes 422,250 restricted stock units.

Content

Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date.

Includes 422,250 restricted stock units.